Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Ranolazine for the Treatment of Chest Pain in HCM Patients (RHYME)

This study has been completed.
Gilead Sciences
Information provided by (Responsible Party):
Duke University Identifier:
First received: November 2, 2012
Last updated: May 11, 2016
Last verified: December 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2016
  Primary Completion Date: November 2015 (Final data collection date for primary outcome measure)